PharmaIN
develops drug-delivery technology for the treatment of heart failure, cancer, metabolic, autoimmune diseases using branded therapeutics... Read morePharmaIN
develops drug-delivery technology for the treatment of heart failure, cancer, metabolic, autoimmune diseases using branded therapeutics... Read more
Founder & CEO
Elijah M Bolotin
News
Nov 18, 2024
PRWeb
Press Release: PharmaIN : PharmaIN Unveils Interim Phase 1b Clinical Data on the Activity and Safety of PHIN-214 in Decompensated Liver Cirrhosis at AASLD - The Liver Meeting 2024
Sep 03, 2024
PRWeb
Press Release: PharmaIN : PharmaIN's dCNP Therapy Shows Promise in Normalizing Tumor Blood Vessels and Reinvigorating Immune Response in Solid Tumor Models.
Jun 13, 2019
BioPortfolio
PharmaIN: Significant benefit to drug delivery excipient leads to deal
Jun 10, 2019
Pharmabiz
PharmaIN: PeptiDream inks partnership with PharmaIN to use PGC technology for discovery programmes
Jun 06, 2019
BioSpace
PharmaIN: PeptiDream Announces Strategic Partnership with Drug-Delivery Expert PharmaIN
Jan 11, 2018
The Pharma Letter
PharmaIN: BRIEF-Shionogi inks deal with American peptide engineering firm
Jan 08, 2018
GLOBALFDI
PharmaIN: PharmaIN and Shionogi Announce Collaboration and $17M Securities Purchase Agreements
Jan 05, 2018
WardsAuto
PharmaIN: PharmaIN and Shionogi Announce Collaboration and $17M Securities Purchase Agreements
Oct 22, 2015
BUSINESS WIRE
Press Release: PharmaIN : Research and Markets: Sarcoidosis - Pipeline Review, H2 2015 - 5 Companies & 8 Drug Profiles
Mar 27, 2015
BIOSPACE
PharmaIN: <b>PolyPeptide Group</b> To Manufacture Protected Graft Copolymer (PGC) For <b>PharmaIN</b>